# Merck KGaA, Darmstadt (Germany)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/merck-kgaa-darmstadt-germany/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 45.5 |
| Citations | 1,494,642 |
| City | Darmstadt |
| Country | DE |
| Description | Merck KGaA, Darmstadt (Germany) is a research organisation in Darmstadt, DE. OpenAlex records 10,389 works and 1,494,642 citations for it. 3,118 researchers list it as their most recent affiliation. |
| Homepage | https://www.emdgroup.com |
| OpenAlex ID | https://openalex.org/I164928964 |
| Region | Hesse |
| Researchers | 3,118 |
| ROR ID | https://ror.org/04b2dty93 |
| Type | company |
| Works | 10,389 |

## University papers

Showing 12 of 15.

- [The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres](https://scholariq.org/papers/the-burden-of-endometriosis-costs-and-quality-of-life-of-women-with/)
- [Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group](https://scholariq.org/papers/terms-definitions-and-measurements-to-describe-sonographic-features-of/)
- [The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey](https://scholariq.org/papers/the-significant-effect-of-endometriosis-on-physical-mental-and-social-wellbeing/)
- [Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE](https://scholariq.org/papers/assisted-reproductive-technology-in-europe-2010-results-generated-from-european/)
- [Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database](https://scholariq.org/papers/mortality-and-comorbidities-in-patients-with-multiple-sclerosis-compared-with-a/)
- [Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis](https://scholariq.org/papers/persistence-with-and-adherence-to-fingolimod-compared-with-other-disease/)
- [A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body Myositis](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-prevalence-studies-of-sporadic/)
- [Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study](https://scholariq.org/papers/relapse-rates-in-patients-with-multiple-sclerosis-switching-from-interferon-to/)
- [Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension](https://scholariq.org/papers/network-meta-analysis-combining-individual-patient-and-aggregate-data-from-a/)
- [Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis](https://scholariq.org/papers/development-of-a-novel-machine-learning-model-to-predict-presence-of/)
- [Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis](https://scholariq.org/papers/comparative-effectiveness-of-fingolimod-versus-interferons-or-glatiramer-acetate/)
- [Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis](https://scholariq.org/papers/expanding-the-use-of-administrative-claims-databases-in-conducting-clinical-real/)

## University researchers

- [Gorana Capkun](https://scholariq.org/researchers/gorana-capkun/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Protein purification and stability](https://scholariq.org/topics/protein-purification-and-stability/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.